Zepatier
Sponsors
University of Pennsylvania, Johns Hopkins University, Mater Misericordiae University Hospital, Massachusetts General Hospital, Albert Einstein Healthcare Network
Conditions
End Stage Renal DiseaseEnd-Stage Renal DiseaseHeart FailureHepatitis CLung DiseasesRenal Failure Chronic
Phase 1
Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
CompletedNCT02743897
Start: 2016-05-01End: 2022-12-31Updated: 2023-06-15
Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)
CompletedNCT03146741
Start: 2017-05-16End: 2019-11-30Updated: 2021-11-22
Transplanting Hepatitis C Lungs Into Negative Lung Recipients
CompletedNCT03724149
Start: 2018-12-12End: 2022-12-31Updated: 2023-04-14
Phase 4
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
CompletedNCT02781649
Start: 2016-07-20End: 2018-01-01Updated: 2018-09-06
The Dublin Zepatier Study
TerminatedNCT02895958
Start: 2018-03-15End: 2019-12-06Updated: 2019-12-10
Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant
WithdrawnNCT03093740
Start: 2018-10-01End: 2021-01-31Updated: 2018-12-20
A Prospective Cohort Study to Improve HCV Care in Dialysis Patients
WithdrawnNCT03791814
Start: 2019-01-01End: 2019-06-30Updated: 2020-02-26